Pan et al. demonstrated that promotion of MDMX ubiquitination and degradation by MDM2 was ARF protein dependent (ARF tumor suppressor, p14ARF in human or p19ARF in mouse) and required the N-terminal domain of ARF protein. The gene discussed is CDKN2A; the disease is neoplasm.